Prescient Healthcare Group
Rakesh serves on Prescient’s Board as a Non-Executive Director. After earning a degree in veterinary medicine, he completed his MS in immunology and his PhD in immunology/oncology at Imperial College, School of Medicine, London. He was then recruited by oncology biotechnology firm Antisoma, which specialized in the development of antibodies-based therapeutics for oncology. After working in oncology drug development for more than a decade, Rakesh joined Prescient in 2007. His renowned expertise in the development and commercialization of biologics makes him an extremely valuable asset to our oncology, immunology and biosimilar clients.
This person is not in the org chart
This person is not in any offices
Prescient Healthcare Group
29 followers
Prescient is a pharma services firm specializing in dynamic decision support and product and portfolio strategy. They partner with clients to turn science into value by helping them understand the potential of their molecules, shaping their strategic plans and allowing their decision making to be the biggest differentiating factor in the success of their products. When companies partner with Prescient, the molecules in their hands have a greater potential for success than the same science in the hands of their competitors.